It is a pharma private limited company based in Thane, Maharashtra, India, established in 2018.
2018 | Thane, Maharashtra, India | ActiveUnibron Pharmaceutical Private Limited, a active private limited company, was established on 04 January 2018 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999MH2018PTC303657. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Kiran Devi Dharmendra Singh (Additional Director), Neha Singh (Additional Director). Past directors included Bhairav Ramanlal Patel, Kajal Sameer Medda, Smitaben Bhairav Patel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-402, Roop Rajat Plaza Chs Ltd, 150 Feet Road , Near Reena Mehta College, Thane, Maharashtra, 401101.
U74999MH2018PTC303657
303657
04 January 2018
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Unibron Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Devi Dharmendra Singh | Additional Director | 16 Feb 2024 | Current |
| Neha Singh | Additional Director | 21 Mar 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Jan 2021 | Past |
| Pramod Abcsdd | Director | 21 Mar 2024 | Past |
| Pramod Abcsdd | Managing Director | 28 Jan 2021 | Past |
| Pramod Abcsdd | Director | 16 Feb 2024 | Past |
| Pramod Abcsdd | Director | 28 Jan 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unibron Pharmaceutical Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Unibron Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Unibron Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unibron Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unibron Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Unibron Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Unibron Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Neha Singh was appointed as a Additional Director was appointed as a Additional Director on 21 Mar 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity Kiran Devi Dharmendra Singh was appointed as a Additional Director was appointed as a Additional Director on 16 Feb 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on Unibron Pharmaceutical Private Limited was registered on 04 Jan 2018 with Roc Mumbai & aged 7 years 11 months as per MCA records. was documented.
The CIN of Unibron Pharmaceutical Private Limited is U74999MH2018PTC303657.
Unibron Pharmaceutical Private Limited is headquartered at A-402, Roop Rajat Plaza Chs Ltd, 150 Feet Road , Near Reena Mehta College, Thane, Maharashtra, 401101.
Unibron Pharmaceutical Private Limited was incorporated on 04 January 2018.
The current directors of Unibron Pharmaceutical Private Limited are
The primary industry of Unibron Pharmaceutical Private Limited is Pharma.
Unibron Pharmaceutical Private Limited is unlisted.
The authorized capital of Unibron Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX